Figure 1 | British Journal of Cancer

Figure 1

From: Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer

Figure 1

Western blot experiment. Phospho-specific antibody recognising activated c-Src (SrcpY416) is shown as a single 60 kDa band (lane 1: control, C). In addition, phosphorylation of c-Src was observed to decrease after treatment with increasing concentrations of the Src kinase inhibitor dasatinib (lanes2–6) and total Src was not affected by this. Tubulin was used as a control.

Back to article page